John W. Mellors

Preclinical assessment of a novel human antibody VH domain targeting mesothelin as an antibody-drug conjugate

D. Dimitrov, R. Ishima, Xiaojie Chu, 2023, Molecular therapy oncolytics.

Assessment of Novel Mesothelin-Specific Human Antibody Domain VH-Fc Fusion Proteins-Based PET Agents

R. Ishima, Xiaojie Chu, Abhinav Bhise, 2023, ACS omega.

Identification of a Fully Human Antibody VH Domain Targeting Anaplastic Lymphoma Kinase (ALK) with Applications in ALK-Positive Solid Tumor Immunotherapy

Chuan Chen, Wei Li, Zening Wang, 2024, Antibodies.

Human antibody VH domains targeting uPAR as candidate therapeutics for cancers

I. Lyakhov, Xiaojie Chu, Wei Li, 2023, Frontiers in oncology.

Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer

Xiaojie Chu, Xianglei Liu, Cynthia Adams, 2024, mAbs.

Use of recombinant retroviruses to characterize the activity of antiretroviral compounds

John W. Mellors, K. Roger, Strair, 1991, Journal of virology.